Exploring the pathological relationships between adamantinomatous craniopharyngioma and contiguous structures with tumor origin
Authors (first, second and last of 16)
The Journal of Neuro-Oncology is a multi-disciplinary journal encompassing basic, applied, and clinical investigations in all research areas as they relate to cancer and the central nervous system. It provides a single forum for communication among neurologists, neurosurgeons, radiotherapists, medical oncologists, neuropathologists, neurodiagnosticians, and laboratory-based oncologists conducting relevant research. The Journal of Neuro-Oncology does not seek to isolate the field, but rather to focus the efforts of many disciplines in one publication through a format which pulls together these diverse interests. More than any other field of oncology, cancer of the central nervous system requires multi-disciplinary approaches. To alleviate having to scan dozens of journals of cell biology, pathology, laboratory and clinical endeavours, JNO is a periodical in which current, high-quality, relevant research in all aspects of neuro-oncology may be found.
Why publish with us
- A unified resource for multi-disciplinary clinicians and researchers in neuro-oncology.
- In our special topical issues, global experts address current challenges and contemporary topics.
- Our internationally renowned advisers collaborate to deliver quick first decisions to authors and rapid publication.
- We provide high levels of author satisfaction, with 92% of our published authors reporting that they would definitely or probably publish with us again.
Journal information
- Editor-in-Chief
-
- Jason P. Sheehan
- Publishing model
- Hybrid (Transformative Journal). How to publish with us, including Open Access
Journal metrics
- 4.506 (2021)
- Impact factor
- 4.444 (2021)
- Five year impact factor
- 20 days
- Submission to first decision (Median)
- 644,588 (2021)
- Downloads
Latest issue
Latest articles
-
-
-
Clinical features of glioma patients who develop pneumocystis pneumonia with temozolomide chemoradiotherapy
Authors (first, second and last of 4)
-
Poor correlation between preclinical and patient efficacy data for tumor targeted monotherapies in glioblastoma: the results of a systematic review
Authors (first, second and last of 7)
-
The “Combo” radiotherapy treatment for high-risk grade 2 meningiomas: dose escalation and initial safety and efficacy analysis
Authors (first, second and last of 12)
This is part of 1 collection:
Journal updates
-
Subscribe to the journal's new YouTube channel
Be sure to check out and subscribe to the new YouTube channel of the Journal of Neuro-Oncology for in-depth discussions with neuro-oncologists and other interested research investigators.
-
The burden of covid-19 in neuro-oncological patients
Covid-19 is acting as an epochal event, not only for the health impact, with an amount of 1.631.310 people infected, but also for political, social and economic consequences.
-
Inpatient and outpatient case prioritization for patients with neuro-oncologic disease amid the COVID-19 pandemic
General guidance for neuro-oncology practitioners from the AANS/CNS Tumor Section and Society for Neuro-Oncology.
-
Milan 2020: COVID-19, neuro-oncology and much more
This viral infection has spread dramatically in Northern Italy and specifically in Lombardy, affecting all aspects of our lives, personally and professionally.
Societies, partners and affiliations
-
-
-
Grupo Interdisciplinario Mexicano de Investigación en NeuroOncología (GIMINO)
-
-
-
-
-
-
About this journal
- Electronic ISSN
- 1573-7373
- Print ISSN
- 0167-594X
- Abstracted and indexed in
-
- BFI List
- Baidu
- CLOCKSS
- CNKI
- CNPIEC
- Chemical Abstracts Service (CAS)
- Current Contents/Clinical Medicine
- Dimensions
- EBSCO Biomedical Reference Collection
- EBSCO Discovery Service
- EMBASE
- Google Scholar
- Japanese Science and Technology Agency (JST)
- Journal Citation Reports/Science Edition
- Medline
- Naver
- Norwegian Register for Scientific Journals and Series
- OCLC WorldCat Discovery Service
- Pathway Studio
- Portico
- ProQuest-ExLibris Primo
- ProQuest-ExLibris Summon
- Reaxys
- SCImago
- SCOPUS
- Science Citation Index
- Science Citation Index Expanded (SCIE)
- Semantic Scholar
- TD Net Discovery Service
- UGC-CARE List (India)
- Wanfang
- Copyright information
-
© Springer Science+Business Media, LLC, part of Springer Nature
